TFF1, Recombinant, Human (TFF-1, pS2, BCEI, HPS, HP1,A, pNR-2, D21S21, pS2 Protein, Trefoil Factor 1, Breast Cancer Estrogen-Inducible Protein, Trefoil Factor Peptide, pS2 Protein, HP1.A, Breast Cancer Estrogen-Inducible Protein (BCEI), PNR2)

Catalog No : USB-220315
471.28€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name TFF1, Recombinant, Human (TFF-1, pS2, BCEI, HPS, HP1,A, pNR-2, D21S21, pS2 Protein, Trefoil Factor 1, Breast Cancer Estrogen-Inducible Protein, Trefoil Factor Peptide, pS2 Protein, HP1.A, Breast Cancer Estrogen-Inducible Protein (BCEI), PNR2)
Catalog No USB-220315
Supplier’s Catalog No 220315
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 8.2
Storage -20°C
Other names
Grade Highly Purified
Purity ~98% (SDS-PAGE, HPLC)
Form Supplied as a lyophilized powder. No preservative added. Reconstitute with sterile ddH2O to 0.1-1mg/ml.
Reactivity life 12 months
Note For reserch purpose only
Purity ~98% (SDS-PAGE, HPLC)
Description The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. Source: Recombinant protein corresponding to 60aa residues from human TFF1, expressed in E. coli. Molecular Weight: ~8.2kD Biological Activity: Determined by its ability to chemoattract human MCF-7 cells using a concentration 5-10ug/ml. Endotoxin: <0.1ng/ug Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months after receipt at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.